Press Release
PharmaDirections Launches PHARMADIRECTNET™
PharmaDirections, Inc, a Cary, North Carolina based Drug Development Management Company, today announced the launch of PHARMADIRECTNET™, an industry leading proprietary network representing over 120 Ph.D. level drug development scientists, regulatory experts and quality experts, and over 40 global laboratory and manufacturing providers. PHARMADIRECTNET™ positions PharmaDirections, Inc. to aggressively meet the needs of the expanding industry demand for outsourced drug development on a global scale.
“As the pharmaceutical industry re-invents itself during this period of global restructuring, both established and emerging biopharmaceutical companies face difficult challenges in being able to access the best scientific, regulatory and quality guidance necessary to build a confident plan to the IND and the NDA, and to then execute that plan, ” states Richard Soltero, Ph.D, President of PharmaDirections. According to Dr. Soltero, “We have structured PharmaDirections on sound scientific experience, supported by regulatory, quality and project management infrastructure. We believe that we represent a new global paradigm in meeting outsourced drug development needs for new pharmaceutical and biotech products. PHARMADIRECTNET™ represents an important next step in our company’s growth. This significantly augments our capacity to continue the rapid growth that PharmaDirections has experienced in the past five years.”
Learn more at: www.PharmaDirections.com
About PharmaDirections: ‘Structured for Science, Built for Speed’
PharmaDirections, Inc, located in North Carolina, focuses on providing outsourced drug development management for pre IND enabling, IND, and post IND CMC critical pathway needs for the pharmaceutical industry. Founded in 2003, PharmaDirections aspires to be the industry’s leading outsource resource for pre IND and CMC drug development.
“As the pharmaceutical industry re-invents itself during this period of global restructuring, both established and emerging biopharmaceutical companies face difficult challenges in being able to access the best scientific, regulatory and quality guidance necessary to build a confident plan to the IND and the NDA, and to then execute that plan, ” states Richard Soltero, Ph.D, President of PharmaDirections. According to Dr. Soltero, “We have structured PharmaDirections on sound scientific experience, supported by regulatory, quality and project management infrastructure. We believe that we represent a new global paradigm in meeting outsourced drug development needs for new pharmaceutical and biotech products. PHARMADIRECTNET™ represents an important next step in our company’s growth. This significantly augments our capacity to continue the rapid growth that PharmaDirections has experienced in the past five years.”
Learn more at: www.PharmaDirections.com
About PharmaDirections: ‘Structured for Science, Built for Speed’
PharmaDirections, Inc, located in North Carolina, focuses on providing outsourced drug development management for pre IND enabling, IND, and post IND CMC critical pathway needs for the pharmaceutical industry. Founded in 2003, PharmaDirections aspires to be the industry’s leading outsource resource for pre IND and CMC drug development.